AbCellera Biologics Inc. (ABCL)
After hours:
| Previous close | 3.9700 |
| Open | 4.0100 |
| Bid | 3.8900 x 100 |
| Ask | 3.9100 x 400 |
| Day's range | 3.8900 - 4.2500 |
| 52-week range | 3.7900 - 8.0500 |
| Volume | |
| Avg. volume | 1,353,201 |
| Market cap | 1.142B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks
In this article, we will take a detailed look at Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks. For a quick overview of such stocks, read our article Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 5 Stocks. Billionaire Stanley Druckenmiller is one of the most revered investors in the Wall Street. […]
- Simply Wall St.
After losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gain
Key Insights Institutions' substantial holdings in AbCellera Biologics implies that they have significant influence...
- Insider Monkey
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript February 20, 2024 AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. […]
